QBiotics leadership transition

2 days ago


Brisbane, Queensland, Australia QBiotics Group Full time
Overview

As part of its leadership transition, the Board of QBiotics is pleased to announce the following changes with effect from 22 October 2024.

- Sue Foden returns to the role of Non-Executive Chair of the Board

- CEO Stephen Doyle appointed to the Board of Directors as Managing Director

- Co-founder, Victoria Gordon retires from QBiotics' executive team while remaining on the Board as a Non-Executive Director.

Dr Sue Foden, who has been fulfilling an executive role overseeing the Company's operations throughout the CEO recruitment process as Executive Chair, will return to the role of Non-Executive Chair. Sue's leadership during this time has been instrumental for preserving the Company's momentum and ensuring its continued stability.

CEO, Stephen Doyle has been appointed to the board of directors as Managing Director.

Dr Victoria Gordon has retired from her position of Executive Director, Strategic Alliances and Investor Relations and will remain on the board as Non-Executive Director. In addition, to ensure smooth transition, Victoria will be available to support Stephen and the senior management team.

Victoria's valuable contributions and strategic vision have been pivotal in shaping the Company since its inception. As a Non-Executive Director, Victoria will continue to contribute to QBiotics' strategic direction - her ongoing presence on the Board ensures continuity and enables the Board to draw upon her deep experience, insights and corporate knowledge.

Sue Foden shared her thanks and appreciation of Victoria's continued involvement, stating, "My thanks go to our Co-founder, Victoria Gordon who will now step away from a QBiotics executive role, while remaining on the Board as Non-Executive Director. We are immensely proud of the many achievements Victoria has overseen through her executive career with the company and are fortunate to retain her skillset and knowledge at the Board level. I extend a warm welcome to her as a Non-Executive Director and look forward to working with her in this new role."

Victoria Gordon responded "I am incredibly proud of everything we've achieved to date at QBiotics. With Stephen now in the role of CEO and Managing Director, I am confident that the business is in safe hands to deliver upon our clinical and commercial milestones. I look forward to supporting both Stephen and the Board as the Company moves forward."

QBiotics is an unlisted public Australian life sciences company that specialises in the discovery and development of novel cell signalling small molecules. QBiotics applies phenotypic screening to generate breakthrough innovation in the discovery of first in class solutions to challenging medical conditions. Our current clinical focus is on novel treatments for cancer and debilitating chronic wounds.

QBiotics' lead oncology drug, tigilanol tiglate, is a small molecule targeting a range of solid tumours and is currently in human clinical Phase II development. A veterinary formulation of tigilanol tiglate is registered and marketed as an oncology pharmaceutical, under the trade name STELFONTA , in the USA, Europe, the UK and Australia.

QBiotics' lead wound healing drug candidate, EBC 1013 is a small molecule targeting a range of wounds including chronic and acute wounds and burns. A first-in-human Phase I clinical development in patients with venous leg ulcers is open for recruitment.

#J-18808-Ljbffr

  • Brisbane, Queensland, Australia QBiotics Group Full time

    OverviewAs part of its leadership transition, the Board of QBiotics is pleased to announce the following changes with effect from 22 October 2024.Sue Foden returns to the role of Non-Executive Chair of the BoardCEO Stephen Doyle appointed to the Board of Directors as Managing DirectorCo-founder, Victoria Gordon retires from QBiotics' executive team while...


  • Brisbane, Queensland, Australia QBiotics Group Full time

    QBiotics appoints Jefferies and Bell Potter as Joint Lead ManagersBRISBANE, 25 March 2025QBiotics Group Limited (QBiotics) is pleased to announce it has appointed Jefferies (Australia) Pty Ltd (Jefferies) and Bell Potter Securities Limited (Bell Potter) as Joint Lead Managers (JLMs) to advise upon and assist QBiotics with a potential initial public offering...

  • Transition Manager

    3 weeks ago


    Brisbane, Queensland, Australia Bluefin Resources Pty Limited Full time

    We're seeking an experienced Program Transition Manager to lead the end-to-end cutover and Hypercare activities for a major ERP transformation. This critical role will ensure a seamless go-live, minimise business disruption, and provide structured post-launch support to drive system stability and operational readiness.You'll work across business, technology,...

  • Transition Manager

    3 weeks ago


    Brisbane, Queensland, Australia Bluefin Resources Pty Limited Full time

    We're seeking an experienced Program Transition Manager to lead the end-to-end cutover and Hypercare activities for a major ERP transformation. This critical role will ensure a seamless go-live, minimise business disruption, and provide structured post-launch support to drive system stability and operational readiness.You'll work across business, technology,...


  • Brisbane, Queensland, Australia beBeeCareerTransition Full time $78,204 - $82,008

    Job Title: Career Transition Specialist Key Role Summary:The successful candidate will lead the operational approach to career transitions, working under the direction of the Head of Campus.This role acts as an integral member of the Senior Learning Hub team, contributing to the life of the school and aligning with the Four Principles and Common Ground...


  • Brisbane, Queensland, Australia beBeeTransition Full time $80,000 - $120,000

    Energy Transition SpecialistAbout the Role:We are seeking a highly organized and proactive individual to support our Chief Executive Officer (CEO) in driving the global shift towards sustainable energy.This pivotal role involves managing the CEO's day-to-day activities, ensuring smooth and efficient operations, and participating in energy-related...


  • Brisbane, Queensland, Australia beBeeCareer Full time $95,000 - $110,000

    High-Level Support RoleThis is a unique opportunity to join a leading energy transition firm as an Executive Officer. Are you passionate about the energy sector and eager to make a significant impact?Managing high-level responsibilities while supporting top leadership.About UsWe drive the global shift towards sustainable energy, leveraging 15-person...


  • Brisbane, Queensland, Australia OnTalent Full time

    Join to apply for the Chief Energy Transition Officer role at On Talent3 days ago Be among the first 25 applicants Join to apply for the Chief Energy Transition Officer role at On Talent Get AI-powered advice on this job and more exclusive features.CS Energy is seeking a Chief Energy Transition Officer (CETO) to lead the development and execution of the...


  • Brisbane, Queensland, Australia At Full time

    Senior Manager, Student Transition and Success$135300 - $143081 p.a.+ 17% super + leave loading This is a full-time continuing position with salary in the range $135,300 - $143,081(HEW 9), plus a generous super allowance of up to 17%.Lead a newly formed team to bring UQ's transition framework to life, shaping student success through data-driven strategies...


  • Brisbane, Queensland, Australia Louise Rana - Limitless Learning Co Full time

    Experienced Educators – Transition into a Rewarding Remote CareerJoin to apply for the Experienced Educators – Transition into a Rewarding Remote Career role at Louise Rana - Limitless Learning CoExperienced Educators – Transition into a Rewarding Remote Career2 days ago Be among the first 25 applicantsJoin to apply for the Experienced Educators –...